Literature DB >> 25186349

Diabetes-induced fibrotic matrix inhibits intramembranous bone healing.

Roozbeh Khosravi1, Philip C Trackman.   

Abstract

Diabetes diminishes bone healing and ossification. Reduced bone formation in intramembranous ossification is known, yet the mechanism(s) behind impaired intramembranous bone healing are unclear. Here we report the formation of a fibrotic matrix during healing of intramembranous calvarial bone defects that appears to exclude new bone growth. Our histological analyses of 7-day and 14-day calvaria bone healing tissue in chemically-induced diabetic mice and non-diabetic mice showed the accumulation of a non-mineralized fibrotic matrix, likely as a consequence of unresolved hematomas under diabetic conditions. Elevated mRNA and enzyme activity levels of lysyl oxidase on day 7 in diabetic bone healing tissues also supports that the formation of a fibrotic matrix occurs in these tissues. Based on these findings, we propose that elevated fibroblast proliferation and formation of a non-mineralized fibrotic extracellular matrix in diabetes contributes to deficient intramembranous bone healing in diabetes. A greater understanding of this process has relevance to managing dental procedures in diabetics in which successful outcomes depend on intramembranous bone formation.

Entities:  

Year:  2014        PMID: 25186349      PMCID: PMC4414841          DOI: 10.1007/s12079-014-0242-x

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  28 in total

1.  Different endogenous threshold levels of Fibroblast Growth Factor-ligands determine the healing potential of frontal and parietal bones.

Authors:  Björn Behr; Nicholas J Panetta; Michael T Longaker; Natalina Quarto
Journal:  Bone       Date:  2010-05-21       Impact factor: 4.398

Review 2.  The missing bone.

Authors:  G A Rodan; S Harada
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

3.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.

Authors:  E Lalla; I B Lamster; M Feit; L Huang; A Spessot; W Qu; T Kislinger; Y Lu; D M Stern; A M Schmidt
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

Review 5.  Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes.

Authors:  R G Paul; A J Bailey
Journal:  Int J Biochem Cell Biol       Date:  1996-12       Impact factor: 5.085

6.  Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-beta 1 and prostaglandin E2.

Authors:  A M Boak; R Roy; J Berk; L Taylor; P Polgar; R H Goldstein; H M Kagan
Journal:  Am J Respir Cell Mol Biol       Date:  1994-12       Impact factor: 6.914

Review 7.  Understanding the pathology and mechanisms of type I diabetic bone loss.

Authors:  Laura R McCabe
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

8.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

9.  Pre- and post-translational regulation of lysyl oxidase by transforming growth factor-beta 1 in osteoblastic MC3T3-E1 cells.

Authors:  E J Feres-Filho; Y J Choi; X Han; T E Takala; P C Trackman
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

10.  TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1.

Authors:  Rayyan A Kayal; Michelle Siqueira; Jazia Alblowi; Jody McLean; Nanarao Krothapalli; Dan Faibish; Thomas A Einhorn; Louis C Gerstenfeld; Dana T Graves
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

View more
  2 in total

1.  Effects of parathyroid hormone (1-34) on the regulation of the lysyl oxidase family in ovariectomized mice.

Authors:  Linyi Cai; Demao Zhang; Wenjing Liu; Yujia Cui; Junjun Jing; Jing Xie; Xuedong Zhou
Journal:  RSC Adv       Date:  2018-08-30       Impact factor: 4.036

Review 2.  Enzymatic and non-enzymatic functions of the lysyl oxidase family in bone.

Authors:  Philip C Trackman
Journal:  Matrix Biol       Date:  2016-01-06       Impact factor: 11.583

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.